fda glp-1 compounded warning september 2025 takes aim at telehealth companies for promoting unofficial weight loss drug dupes FDA Moves to Restrict Mass-Marketed

Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial

You pay a one-time consultation fee of $89, plus the ongoing $39 monthly membership fee, which gets you access to more competitively priced GLP-1s

Dulaglutide Dulaglutide (Trulicity) is administered subcutaneously at a maximum dose of 1.5 mg once weekly, and available on license since 2014 for people with T2D as monotherapy in those who cannot take metformin or as add-on treatment in people using oral agents and/or insulin

and metabolism 19 (9), 12421251

Helps Reduce Cravings and Appetite: Supports lower hunger levels, reduced snacking, and more balanced eating patterns

This multifaceted approach not only supports weight loss but also addresses key factors in managing type 2 diabetes effectively